Wuhan Keqian Biology Co.,Ltd (688526.SS) SHH
13.06
-0.21(-1.58%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Wuhan Keqian Biology Co.,Ltd
Sector
Healthcare
Industry
Biotechnology
Employees
923
First IPO Date
September 22, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Tiantian Zou | Board Secretary | 0 | 1983 |
| Ming Zhong | Chief Financial Officer, Deputy GM & Vice Chairman | 0 | 1983 |
| Guanping Chen | Deputy General Manager | 0 | 1967 |
| Xibiao Tang | Deputy General Manager | 0 | 1980 |
| Gaoyuan Xu | Executive Deputy General Manager | 0 | 1976 |
| Mulin Chen | GM & Chairman | 0 | 1988 |
| Chan Cha Chen | Accounting Supervisor | 0 | N/A |
| Deng Hong | Deputy General Manager | 0 | 1984 |
Description
Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. It offers vaccines for swine, poultry, and pets, as well as diagnostic reagents. The company was founded in 2001 and is based in Wuhan, China.
